Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 01:38:52 EDT

Explore

PostsPeople
LatestRanked
@idfe.bsky.socialOct 9, 2026, 12:24 PM

๐Ÿ“ฌ Check your emails! Our September #newsletter is out!
๐Ÿ“‘ Read our editorial on #EUScreeningWeek
๐Ÿ“ฃ Learn about our our #EASD Symposium on diabetes education
๐Ÿ“ฐ Stay informed with health-related #news
๐Ÿ”ฌ Discover updates from our #researchprojects
โžก createsend.com/t/t-2DA89DF2...

@aiinmeditech.bsky.socialOct 6, 2026, 6:38 AM

What makes EASD influential among diabetes experts?

Our latest KOL study examines scientific credibility, emerging treatment evidence, clinical influence, and future opportunities.

Explore the findings:
www.sperresearch.com/Case-Studies...

#EASD #DiabetesResearch #KOLInsights #Healthcare

@nursinginpractice.bsky.socialOct 3, 2026, 3:03 PM

Healthcare professionals should routinely discuss the emotional impact of diabetes with patients, according to a clinical practice guideline developed by the European Association for the Study of Diabetes (EASD).

#EASD #Diabetes

buff.ly/OM9k1OK

@biotechhangout.bsky.socialOct 2, 2026, 1:24 PM

#BiotechHangout Graig Suvannavejh, Sam Fazeli, Eric Schmidt & Brian Skorney on biotech market review & IPOs, $MRNA on Nasdaq 100, deals: $AZN/$SMMT, AZN-Daiichi-$SMMT, $NVO/Hengrui, $REGN/$SNY, company news: $MIRM, $ABBV, $MRK, data: $DYN, $MIRM, $KOD, $IMMX, $QURE, #EASD, #WCLC, #AAO bit.ly/3TFmfQK

@newsen.bsky.socialOct 2, 2026, 12:48 PM

EASD 2026: Phase III Results of Olatorepatide Show Significant Weight Loss Benefits #Italy #Milan #Hansoh_Pharma #EASD #Olatorepatide

@newsen.bsky.socialOct 2, 2026, 12:14 PM

Significant Weight Loss Achieved with Olatorepatide in Phase III Study Presented at EASD 2026 #Italy #Milan #Hansoh_Pharma #EASD #Olatorepatide

@pharmaphorum.bsky.socialOct 2, 2026, 12:13 PM

As the #EASD congress draws to a close, here's a round-up of some of the other #clinicaltrials in #diabetes and #obesity that drew our attention.

pharmaphorum.com/news/new-dia...

@metabologiajnl.bsky.socialOct 1, 2026, 6:30 AM

#EASD/#EFSD Rising Star 2026 Carla Horvath (@ETH Zurich, @D-HEST) explores how menopausal oestrogen loss rewires adipocytes, shifting lipid storage and raising risk of type 2 diabetes and #MASLD. #Menopause #AdiposeTissue link.springer.com/article/10.1...

@metabologiajnl.bsky.socialOct 1, 2026, 6:30 AM

2026 #EASD/#EFSD Rising Star @Sara Stinson examines multi-omic trajectories of #Alzheimer's disease, revealing a shared geneticโ€“metabolic signature with #Type2Diabetes. #T2D #MultiOmics #OsloUniveristyHospital #UniversityofOslo link.springer.com/article/10.1...

@metabologiajnl.bsky.socialOct 1, 2026, 6:30 AM

2026 #EASD/#EFSD Rising Star @AaronNovikoff brings to light novel strategies in anti-obesity #incretin pharmacology, redirecting focus away from poly-receptor agonism and towards the untapped potential of precision pharmacodynamics. #AntiObesity #Pharmacology link.springer.com/article/10.1...

@metabologiajnl.bsky.socialOct 1, 2026, 6:30 AM

Adults with single islet #autoantibodies who develop diabetes donโ€™t all follow same path; some need early #insulin, others don't. 2026 #EASD/#EFSD Rising Star Nicholas Thomasโ€™ research investigates whoโ€™s at greatest risk of needing insulin & how to predict this link.springer.com/article/10.1...

@newsen.bsky.socialSep 30, 2026, 11:45 PM

Sinocare Unveils Comprehensive Chronic Disease Management Solutions at EASD 2026 Conference #Italy #Milan #Chronic_Disease #Sinocare #EASD

@financiernews.bsky.socialSep 30, 2026, 8:00 PM

๐Ÿฅ‡ Lilly Slides 2% As EASD Deck Lands With No New Guidance

Eli Lilly presented at the 2026 EASD annual meeting, publishing a slide deck tied to the event.

Shares fell 2.02% to 1,160.75, holding the 82nd percentile of the 52-week range after a 7.44% YTD run.

#EASD #Lilly

https://financier.news/

Eli Lilly Stock Drops 2% as EASD 2026 Slide Deck Lands With No New Guidance, Shares Hold 82nd Percentile ofโ€ฆ
@lc-stene.bsky.socialSep 29, 2026, 1:25 PM

#Oslo Diabetes Research Centre associate at #EASD: Prof Tore J Berg presenting on upper limb complications - understudied in diabetes

@explora-guide78.bsky.socialSep 29, 2026, 9:30 AM

There is more to Milan than the conference programme.

Turns the gaps between sessions into a self-guided discovery trail through the cityโ€™s history.

Special Collection Code: DIABETES-MILAN

explora.guide/conference/

#Milan #EASD

@ispadsociety.bsky.socialSep 24, 2026, 12:02 PM

A new international consensus report endorsed by #ISPAD, #EASD and #ADA provides guidance across the full transition of care continuum while recognizing the need to adapt these recommendations to local settings.

๐Ÿ“– Read the full consensus report: https://loom.ly/Wel8FXE

#ISPAD #ISPAD2026

@easdnews.bsky.socialSep 24, 2026, 9:09 AM

๐Ÿ“ข๐ŸŽค๐’๐๐„๐€๐Š๐„๐‘ ๐‡๐ˆ๐†๐‡๐‹๐ˆ๐†๐‡๐“: Join Prof. Dame Melanie Davies & Prof. John Buse at #EASD2026 in Milan for the " #ADA / #EASD consensus report on the management of type 2 #diabetes"๐Ÿ‡ฎ๐Ÿ‡น

๐Ÿ“… Fri, 2 Oct 2026 | 13:00 CEST |๐Ÿ“London Hall

Learn more ๐Ÿ‘‰ pagv3.virtual-meeting.org/EASD/easd202...

#ConsensusReport #T2D

Navy blue promotional graphic for the EASD 2026 Annual Meeting in Milan. A red banner at the top reads "Management of Type 2 Diabetes." Below, white text reads "ADA/EASD consensus report on the management of type 2 diabetes," followed by session details: "2 October 2026 | 13:00 - 14:00 | London Hall." Two circular headshots below show a woman with shoulder-length blonde hair and glasses, and a smiling older man with white hair, a beard, and a blue tie. Red banners beside the photos display their names, "Prof. Dame Melanie Davies" and "Prof. John Buse." The EASD 2026 Milan logo, styled as a row of cathedral spires, appears in the bottom left, with "easd.org" in the bottom right corner.
@diabetologiajnl.bsky.socialSep 21, 2026, 6:00 PM

Review of 248 RCTs: #DiabetesDistress can be reduced. Psychological support helps in type 1 & type 2 #Diabetes, CGM lowers distress in type 1 diabetes, & education works in type 2 diabetes. Targeted strategies matter link.springer.com/article/10.1... #MentalHealth #DiabetesCare #EASD ๐Ÿ”“๏ธ